Cargando…

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies

Detalles Bibliográficos
Autores principales:	Gaspar, Emanuelle Baldo, De Gaspari, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857056/ https://www.ncbi.nlm.nih.gov/pubmed/33581919 http://dx.doi.org/10.1016/j.vaccine.2021.02.003

Ejemplares similares

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
por: Gaspar, Emanuelle B., et al.
Publicado: (2021)

A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022)

Modified ELISA for antibody avidity evaluation: The need for standardization
por: Correa, Victor Araujo, et al.
Publicado: (2021)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
por: Bowsher, Ronald R., et al.
Publicado: (2020)

Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
por: Moura, Andrew D., et al.
Publicado: (2021)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
por: Mahla, Ranjeet Singh, et al.
Publicado: (2022)

Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)

Immunogenicity of antigens from outer membrane vesicles of Neisseria meningitidis associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice
por: Rinaldi, Fabiana Mahylowski, et al.
Publicado: (2021)

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
por: Garcia, Laura, et al.
Publicado: (2022)

Longitudinal SARS-CoV-2 Antibody Avidity Responses in a SARS-CoV-2 Pregnancy Cohort
por: Cassidy, Arianna, et al.
Publicado: (2022)

Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity
por: Liu, Hejun, et al.
Publicado: (2020)

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
por: Liu, Hejun, et al.
Publicado: (2020)

Avidity of anti-phospholipid antibodies in relation to their levels
por: FIALOVÁ, LENKA, et al.
Publicado: (2020)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
por: Monroe, Jonathon M., et al.
Publicado: (2022)

SARS-CoV-2 diagnostics: Some reflections on current assays
por: Antonelli, Guido, et al.
Publicado: (2021)

Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
por: Obeng, Eugene M., et al.
Publicado: (2022)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

The challenge of avidity determination in SARS‐CoV‐2 serology
por: Bauer, Georg, et al.
Publicado: (2021)

Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies
por: Tani, Chiara, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
por: Benner, Sarah E, et al.
Publicado: (2020)

Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients
por: Labropoulou, Stavroula, et al.
Publicado: (2022)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status
por: Peaper, David R., et al.
Publicado: (2021)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
por: Dapporto, Francesca, et al.
Publicado: (2022)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon
por: Rodrigues, Eliene Putira Sacuema, et al.
Publicado: (2021)

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
por: Caruso, Teresita, et al.
Publicado: (2023)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW
por: Plebani, Mario
Publicado: (2020)

Avidity in antibody effector functions and biotherapeutic drug design
por: Oostindie, Simone C., et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design
por: Scheiblauer, Heinrich, et al.
Publicado: (2022)

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022)

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants
por: Du, Wenjuan, et al.
Publicado: (2023)

My Experience with SARS-CoV-2, with a Focus on Testing
por: Cotter, Peggy A.
Publicado: (2020)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021)

Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses
por: Portilho, Amanda Izeli, et al.
Publicado: (2022)

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffgt1ijnmb12u75g1d8e4fsp93